Sees Q4 adjusted EBITDA $8M-$9M. CareDx (CDNA) reported preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA: